HomepageEUFA3 • BVMF
add
Eurofarma Laboratorios SA
Marktnieuws
CNBC
16 uur geleden
Private equity stocks like Apollo are among the most oversold names in the S&P 500
0,43%
Financiële informatie
Resultatenrekening
Opbrengst
Netto inkomsten
| (BRL) | sep 2025info | Wijziging j-o-j |
|---|---|---|
Opbrengst | 3,21Â mld. | 14,03% |
Bedrijfskosten | 1,41Â mld. | -8,77% |
Netto inkomsten | 357,84Â mln. | 165,02% |
Netto winstmarge | 11,15 | 132,29% |
Winst per aandeel | — | — |
EBITDA | 825,36Â mln. | 89,77% |
Effectief belastingtarief | 10,45% | — |
Balans
Totale activa
Totale passiva
| (BRL) | sep 2025info | Wijziging j-o-j |
|---|---|---|
Contanten en kortetermijnbeleggingen | 1,29Â mld. | -40,20% |
Totale activa | 17,83Â mld. | 3,99% |
Totale passiva | 12,90Â mld. | 3,31% |
Totaal aandelenvermogen | 4,93 mld. | — |
Uitstaande aandelen | 989,21 mln. | — |
Koers-boekwaardeverhouding | — | — |
Rendement op activa | 10,11% | — |
Rendement op kapitaal | 12,00% | — |
Kasstroom
Nettomutatie in liquide middelen
| (BRL) | sep 2025info | Wijziging j-o-j |
|---|---|---|
Netto inkomsten | 357,84Â mln. | 165,02% |
Operationele kasstroom | 502,28Â mln. | -4,09% |
Kasstroom uit beleggingen | -127,54Â mln. | 62,89% |
Kasstroom uit financiering | -576,73Â mln. | -404,59% |
Nettomutatie in liquide middelen | -212,73Â mln. | -163,15% |
Vrije kasstroom | -231,08Â mln. | -15,34% |
Over
Eurofarma is a Brazilian multinational corporation engaged in biopharmaceutical manufacturing and is one of the largest medicine producers in Brazil and Latin America. Founded in 1972, Eurofarma offers generic, oncologic and veterinary medications. Within Brazil the company is responsible for about 2000 products, representing 66% of the total market.
Eurofarma has active operations in 20 countries, with factories in Brazil, Argentina, Bolivia, Chile, Colombia, Ecuador, Guatemala, Mexico, Mozambique, Paraguay, Peru, Uruguay and Venezuela. Wikipedia
Opgericht
1972
Website
Werknemers
13.000
